Table 3.
Weighted and Unweighted Dichotomous Effect Sizes for Each Study
Study | General LOR + (OR) | GI LOR + (OR) | Gyn LOR + (OR) | Pain LOR + (OR) | CP LOR + (OR) | Obesity LOR + (OR) |
---|---|---|---|---|---|---|
Aaron & Hughes (2007) | – | – | – | – | – | 13.56 (2.00) |
Bendixen et al. (1994) (female sample) | – | – | 9.09 (1.65) | 5.98 (1.59) | – | – |
Bendixen et al. (1994) (male sample) | – | – | −0.40 (.65) | 0.61 (1.35) | – | – |
Brown et al. (2005) | – | – | – | 9.28 (4.66) | – | – |
Chartier et al. (2007) | 73.00 (1.66) | – | – | 15.77 (1.25) | – | – |
Chartier et al. (2009) | – | – | – | – | – | 43.99 (1.59) |
Dong et al. (2004 | – | – | – | – | 81.09 (1.31) | – |
Draper et al. (2008) | 99.14 (1.35) | – | – | – | 38.65 (1.25) | – |
Ernst et al. (1993) | – | – | 4.64 (2.37) | – | – | – |
Felitti (1991) | – | 3.72 (2.78) | – | 10.67 (2.45) | – | 16.96 (4.06) |
Finestone et al. (2000) | – | – | – | 4.24 (2.95) | – | – |
Goodwin & Stein (2004) | – | 12.83 (2.02) | – | 22.03 (1.60) | 22.53 (1.81) | – |
Hulme (2000) | – | 7.70 (1.93) | 6.79 (2.11) | 9.51 (1.81) | 11.11 (3.66) | – |
Jamieson & Steege (1997) | – | 3.49 (2.70) | 17.17 (1.84) | 11.66 (1.64) | – | – |
Lechner et al. (1993) | – | 5.07 (3.52) | 8.50 (1.78) | 10.09 (1.91) | 2.50 (1.68) | – |
Newman et al. (2000) | – | 2.35 (1.71) | – | 10.97 (1.66) | – | – |
Noll et al. (2007) | – | – | – | – | – | 5.29 (1.84) |
Sachs-Ericsson et al. (2005) | 39.60 (1.82) | – | – | – | – | – |
Sickel et al. (2002) | – | – | 4.10 (1.79) | – | – | 5.58 (2.33) |
Walker, Gelfand et al. (1999) | – | 2.03 (1.63) | 22.87 (1.89) | 19.20 (1.92) | 12.87 (2.78) | 24.19 (1.96) |
Williamson et al. (2002) | – | – | – | – | – | 81.19 (1.61) |
Wilsnack et al. (1997) | – | – | 25.74 (1.94) | – | – | – |
Note. GI: gastrointestinal health; Gyn: gynecologic health; CP: cardiopulmonary health.